Jun 28, 2025, 21:56

DoD FY25 Ovarian Cancer Clinical Trial Academy – Early-Career Investigator Award

Supports early-career clinical trialists in ovarian cancer through 4 years of funding, intensive mentoring, leadership development, and networking within the OCCTA to design and execute small-scale, translational clinical trials that address critical gaps in ovarian cancer treatment and survivorship .

Eligibility Criteria:

Applicant Organization: Extramural or intramural U.S. or foreign academic institutions, biotechnology companies, foundations, DOD laboratories, and other public or private entities (for-profit or non-profit) .
Principal Investigator (ECI): Within 12 years of most recent postdoctoral or clinical fellowship at full application deadline; must commit ≥25% effort to the award and OCCTA activities for the first 2 years. Current postdocs/fellows are not eligible.
Designated Mentor: Established clinical trialist with active ovarian cancer trial and strong mentorship record; must devote ≥5% effort to OCCTA mentoring; cannot be current OCCTA Dean/Assistant Dean .
Other Mentor (if needed): Independent ovarian cancer clinical researcher at same institution as ECI, to supplement mentorship.
Human Subjects: Supports translational research and early-phase clinical trials (small-scale, phase 1/2 or phase 2); interventional trials must include IRB/IND or IDE documentation; observational clinical research is exempt.
Consumer Advocates: Encouraged to involve ovarian cancer survivors as advocates in study design, oversight, and dissemination.

Funding Details:

Total Cost Cap: $1.4 million total costs (direct + indirect) over up to 4 years
Use of Funds: Personnel (including mentor support), travel for annual OCCTA workshop and one scientific meeting per year, supplies, equipment, conferencing tools, data management; indirect costs per negotiated rates. No tuition or trial initiation costs. .

Deadline:

Pre-Application (Preproposal): June 12, 2025, 5 p.m. ET
Invitation to Submit Full Application: July 17, 2025
Full Application: September 11, 2025, 11:59 p.m. ET
Application Verification Ends: September 16, 2025, 5 p.m. ET

Where to Go for Further Information & Application:

eBRAP Portal: (required for pre-applications and intramural submissions)
General Application Instructions

cancer CDMRP clinical trial consumer-advocacy DoD early career investigator eBRAP mentorship OCCTA OncoDaily Oncology Ovarian Cancer translational research

25 Posts Not To Miss From ESMO GI 2025

Botensilimab and Balstilimab Show Durable Survival in MSS Colorectal Cancer: ESMO GI 2025 Update

Julian McMahon Dies at 56: A Look Back at His Private Cancer Battle and Legendary Acting Career

Vivek Subbiah: It’s Time We Evolve WHO Cancer Classification

ESMO 50th Anniversary: Half a Century of Evidence-Based Cancer Care